The present invention relates to a composition comprising a hydrophilic drug and an amphiphilic carbohydrate compound for use in therapy wherein the composition is intranasally administered to the human or animal body. The composition can be used to treat a variety of disorders, including schizophrenia, obesity, pain and sleep disorders, psychiatric diseases, neurodegenerative conditions, brain cancers and infective diseases.
|IPC||A61K 47/36 (2006.01), A61K 38/08 (2006.01)|
|Publication status||Published - 7 May 2015|
- Peptide, Nanomedicines, Nasal